Because of this, investors will want to remove the list of stocks that Goldman Sachs recently decided to upgrade and boost. This is especially the case since the bank also recommended their underlying ...

There is so much financial advice out there — and everyone talks about living below their means. But how can that affect your money in the long run? “I’ve spent years advising people on the ...

Warren Buffett is known for advising investors to stay within their circle of competence, which means not buying or even considering businesses or industries that the investor cannot understand. He ...

It makes sense for deregulation to be a passion project for people like Bezos, whose operation has 1.52 million employees scattered across the world, but what would such initiatives mean for you ...

President-elect Donald Trump’s promise to levy strict tariffs — essentially, taxes and trade penalties — upon America’s trade partners has made many economists, as well as everyday ...

With RWJ trading at a recent price near $45.91 per unit, that means that analysts see 19.13% upside for this ETF looking through to the average analyst targets of the underlying holdings.

This means the Pentagon really must keep funding the NGAD -- notwithstanding reports last year that it might cancel the program over cost concerns. That's good news for Lockheed, which I have to ...

What does it mean when one of the world’s most successful investors is sitting on such a giant pile of cash, and how should investors react? Here are some of the potential reasons for Buffett ...

Verona Pharma PLC American Depositary Share (VRNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in ...

For Zentalis Pharmaceuticals, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of ...

With IJS trading at a recent price near $108.14 per unit, that means that analysts see 21.32% upside for this ETF looking through to the average analyst targets of the underlying holdings.

Investors might want to bet on Q32 Bio (QTTB), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...